Read + Share
Li Z, Li X, Li S, Tao R, et al. Preclinical evaluation and phase 1 study of the PI3Kalpha/delta inhibitor TQ-B3525 in
Chinese patients with advanced cancers. Cancer 2024;130:3686-3698.
PMID: 38926891
|
 |
|
Li Z, Li X, Li S, Tao R, et al. Preclinical evaluation and phase 1 study of the PI3Kalpha/delta inhibitor TQ-B3525 in
Chinese patients with advanced cancers. Cancer 2024;130:3686-3698.
PMID: 38926891
|
|
|
|